StoneX Group’s 4D Pharma PLC LBPS Stock Holding History

StoneX Group’s Portfolio LBPS Stock Details LBPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,896	Closed	-$86.6K	–	686
2021 Q4	$86.6K	Buy	+15,896	New	+$107K	0.01%	543

Other funds holding LBPS

Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

StoneX Group's LBPS Position: Q1 2022 in Review

StoneX Group sold out of 4D Pharma PLC (LBPS) in Q1 2022, closing a stake of 15,896 shares — an estimated $86.6K sold.

StoneX Group first reported a position in LBPS in Q4 2021 and held it in 1 quarter. The position peaked at $86.6K in Q4 2021. 10 funds tracked by Wall St. Rank hold LBPS as of Q1 2022.

StoneX Group reported no remaining 4D Pharma PLC position as of Q1 2022 after selling out during the quarter.
StoneX Group sold 15,896 4D Pharma PLC shares in Q1 2022, an estimated $86.6K.
StoneX Group first reported a position in 4D Pharma PLC in Q4 2021 and held it in 1 quarter.
StoneX Group's 4D Pharma PLC position peaked at $86.6K in Q4 2021.
10 funds tracked by Wall St. Rank held 4D Pharma PLC as of Q1 2022.

Based on StoneX Group's 13F filing for Q1 2022, filed 11 May 2022.